Recombinant urate oxidase (Rasburicase): A new targeted therapy for prophylaxis and treatment of patients with hematologic malignancies at risk of tumor lysis syndrome

被引：4

作者：

Cairo, MS ^{[1
]}

机构：

[1] Columbia Univ, Dept Pediat, New York, NY 10027 USA

来源：

CLINICAL LYMPHOMA | 2003年 / 3卷 / 04期

关键词：

D O I：

10.1016/S1526-9655(11)70183-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：233 / 234

页数：2

共 12 条

[1]

BROGARD JM, 1972, REV EUR ETUD CL BIOL, V17, P890

[2]

Coiffier B, 2002, BLOOD, V100, p359A

[3] USE OF ALLOPURINOL FOR PREVENTION AND CONTROL OF HYPERURICEMIA IN PATIENTS WITH NEOPLASTIC DISEASE [J].

DECONTI, RC ;

CALABRESI, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (09) :481-+

[4]

DUCROS J, 1991, CLIN NEPHROL, V35, P89

[5] A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis [J].

Goldman, SC ;

Holcenberg, JS ;

Finklestein, JZ ;

Hutchinson, R ;

Kreissman, S ;

Johnson, FL ;

Tou, C ;

Harvey, E ;

Morris, E ;

Cairo, MS .

BLOOD, 2001, 97 (10) :2998-3003

[6]

Jeha S, 2002, BLOOD, V100, p556A

[7] URATE-OXIDASE PROPHYLAXIS OF URIC ACID-INDUCED RENAL DAMAGE IN CHILDHOOD LEUKEMIA [J].

MASERA, G ;

JANKOVIC, M ;

ZURLO, MG ;

LOCASCIULLI, A ;

ROSSI, MR ;

UDERZO, C ;

RECCHIA, M .

JOURNAL OF PEDIATRICS, 1982, 100 (01) :153-155

[8] Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies [J].

Pui, CH ;

Relling, MV ;

Lascombes, F ;

Harrison, PL ;

Struxiano, A ;

Mondesir, JM ;

Ribeiro, RC ;

Sandlund, JT ;

Rivera, GK ;

Evans, WE ;

Mahmoud, HH .

LEUKEMIA, 1997, 11 (11) :1813-1816

[9]

Pui CH, 2002, BLOOD, V100, p556A

[10] Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma [J].

Pui, CH ;

Mahmoud, HH ;

Wiley, JM ;

Woods, GM ;

Leverger, G ;

Camitta, B ;

Hastings, C ;

Blaney, SM ;

Relling, MV ;

Reaman, GH .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :697-704

← 1 2 →